BACKGROUND: While pathological and magnetic resonance imaging-based tumor regression grading systems are widely utilized following neoadjuvant therapy for rectal cancer, existing e
A 36-year-old man with no family history of colorectal cancer or inflammatory bowel disease presented with a 3-month history of bright red blood per rectum and constipation. Anosco
Retrospective propensity-matched cohort study showing no difference in overall survival between radiation regimens in total neoadjuvant therapy for rectal cancer, confirming equipoise between approaches already in clinical use.
A retrospective, single-center machine learning study shows superior prognostic stratification versus conventional staging in locally advanced rectal cancer, but lacks prospective validation and external multi-center confirmation needed to guide clinical practice.